Comparison of CTX-M-14- and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae isolates from patients with bacteremia

Journal of Infection

Volumn 63, Issue 1, 2011, Pages 39-47

  Shin, Juyoun ^a   Kim, Dae Hun ^a   Ko, Kwan Soo ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

Author keywords

Addiction systems; CTX M; ESBL; MLST; Virulence determinants

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 14; BETA LACTAMASE CTX M 15; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; UNCLASSIFIED DRUG;

AFA GENE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CNF GENE; CONTROLLED STUDY; ENZYME SYNTHESIS; ESCHERICHIA COLI; FYUA GENE; HYLA GENE; IBEA GENE; IN VITRO STUDY; IUTA GENE; KLEBSIELLA PNEUMONIAE; KOREA; KPSM II GENE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PAPA GENE; PAPG GENE; PHYLOGENY; POLYMERASE CHAIN REACTION; SFA GENE; STRAIN DIFFERENCE; TRAT GENE;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; DATABASES, NUCLEIC ACID; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; HUMANS; KLEBSIELLA PNEUMONIAE; POLYMERASE CHAIN REACTION; REPUBLIC OF KOREA;

EID: 79959623248     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.05.003     Document Type: Article

References (38)

1. Bonnet R. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004, 48(1):1-14.
2. Cantón R., Coque T.M. The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 2006, 46:2605-2612.
3. Rossolini G.M., D'Andrea M.M., Mugnaidol C. The spread of CTX-M-type extended-spectrum β-lactamases. Clin Microbiol Infect 2008, 14(Suppl. 1):33-41.
4. Karim A., Poirel L., Nagarajan S., Nordmann P. Plasmid-mediated extended-spectrum β-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol Lett 2001, 201:237-241.
5. Coelho A., Mirelis B., Alonso-Tarrés C., Nieves Larrosa M., Miró E., Clivillé Abad R., et al. Detection of three stable genetic clones of CTX-M-15-producing Klebsiella pneumoniae in the Barcelona metropolitan area, Spain. J Antimicrob Chemother 2009, 64:862-864.
6. Ko K.S., Lee J.Y., Baek J.Y., Suh J.Y., Lee M.Y., Choi J.Y., et al. Predominance of an ST11 ESBL-producing Klebsiella pneumoniae clone causing bacteraemia and urinary tract infections in Korea. J Med Microbiol 2010, 59:822-828.
7. Lytsy B., Sandegren L., Tano E., Torell E., Andersson D.I., Melhus A. The first major extended-spectrum beta-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15. APMIS 2008, 116:302-308.
8. Muzaheed Doi Y., Adams-Haduch J.M., Endimiani A., Sidjabat H.E., Gaddad S.M., Paterson D.L. High prevalence of CTX-M-15-producing Klebsiella pneumoniae among inpatients and outpatients with urinary tract infection in Southern India. J Antimicrob Chemother 2008, 61:1393-1394.
9. Shu J.C., Chia J.H., Kuo A.J., Su L.H., Wu T.L. A 7-year surveillance for ESBL-producing Escherichia coli and Klebsiella pneumoniae at a university hospital in Taiwan: the increase of CTX-M-15 in the ICU. Epidemiol Infect 2010, 138:253-263.
10. Pitout J.D., Laupland K.B. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8:159-166.
11. Blanco M., Alonso M.P., Nicolas-Chanoine M.H., Dahbi G., Mora A., Blanco J.E., et al. Molecular epidemiology of Escherichia coli producing extended-spectrum β-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2009, 63:1135-1141.
12. Coque T.M., Novais A., Carattoli A., Poirel L., Pitout J., Peixe L., et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg Infect Dis 2008, 14:195-200.
13. Nocolas-Chanoine M.H., Blanco J., Leflon-Guibout V., Demarty R., Alonso M.P., Caniça M.M., et al. Intercontinental emergence of Escherichia coli clone O25: H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008, 6:273-281.
14. Peirano G., Pitout J.D. Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010, 35:316-321.
15. Peirano G., Richardson D., Nigrin J., McGeer A., Loo V., Toye B., et al. High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum β-lactamase-producing Escherichia coli isolates from Canada. Antimicrob Agents Chemother 2010, 54:1327-1330.
16. Johnson J.R., Menard M., Johnston B., Kuskowski M.A., Nichol K., Zhanel G.G. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 2009, 53:2733-2739.
17. Marcade G., Deschamps C., Boyd A., Gautier V., Picard B., Branger C., et al. Replicon typing of plasmids in Escherichia coli producing extended-spectrum β-lactamases. J Antimicrob Chemother 2009, 63:67-71.
18. Pitout J.D., Laupland K.B., Church D.L., Menard M.L., Johnson J.R. Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum β-lactamase. Antimicrob Agents Chemother 2005, 49:4667-4670.
19. Mnif B., Vimont S., Boyd A., Bourit E., Picard B., Branger C., et al. Molecular characterization of addiction systems of plasmids encoding extended-spectrum β-lactamases in Escherichia coli. J Antimicrob Chemother 2010, 65:1599-1603.
20. Woodford N., Karisik E., Underwood A., Ellington M.J., Carattoli A., Livermore D.M. Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone. Antimicrob Agents Chemother 2009, 53:4472-4482.
21. Hayes F. Toxins-antitoxins: plasmid maintenance, programmed cell death, and cell cycle arrest. Science 2003, 301:1496-1499.
22. Pai H., Choi E.H., Lee H.J., Hong J.Y., Jacoby G.A. Identification of CTX-M-14 extended-spectrum β-lactamases in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea. J Clin Microbiol 2001, 39:3747-3749.
23. Ryoo N.H., Kim E.C., Hong S.G., Park Y.J., Lee K., Bae I.K., et al. Dissemination of SHV-12 and CTX-M-type extended-spectrum β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J Antimicrob Chemother 2005, 56:698-702.
24. Ko K.S., Lee M.Y., Song J.H., Lee H., Jung D.S., Jung S.I., et al. Prevalence and characterization of extended-spectrum β-lactamase-producing Enterobacteriaceae isolated in Korean hospitals. Diagn Microbiol Infect Dis 2008, 61:453-459.
25. Lee M.Y., Choi H.J., Choi J.Y., Song M., Song Y., Kim S.W., et al. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea. J Infect 2010, 60:146-153.
26. Performance standards for antimicrobial susceptibility testing 2009, Clinical and Laboratory Standards Institute, 19th informational supplement. Document M100-S19, CLSI, Wayne, PA, USA.
27. Kim J., Lim Y.M., Rheem I., Lee Y., Lee J.C., Seol S.Y., et al. CTX-M and SHV-12 β-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea. FEMS Microbiol Lett 2005, 245:93-98.
28. Clermont O., Bonacorsi S., Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000, 66:4555-4558.
29. Lau S.H., Reddy S., Cheesbrough J., Bolton F.J., Willshaw G., Cheasty T., et al. Major uropathogenic Escherichia coli strain isolated in the northwest of England by multilocus sequence typing. J Clin Microbiol 2008, 46:1076-1080.
30. Diancourt L., Passet V., Verhoef J., Grimont P.A., Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 2005, 43:4178-4182.
31. Johnson J.R., Stell A.L. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000, 181:261-272.
32. Moreno E., Planells I., Prats G., Planes A.M., Moreno G., Andreu A. Comparative study of Escherichia coli virulence determinants in strains causing urinary tract bacteremia vs. strains causing pyelonephritis and other sources of bacteremia. Diagn Microbiol Infect Dis 2005, 53:93-99.
33. Woodford N. Successful, multiresistant bacterial clones. J Antimicrob Chemother 2008, 61:233-234.
34. Mihaila L., Wyplosz B., Clermont O., Garry L., Hipeaux M.C., Vittecoq D., et al. Probable intrafamily transmission of a highly virulent CTX-M-3-producing Escherichia coli belonging to the emerging phylogenetic subgroup D2 O102-ST405 clone. J Antimicrob Chemother 2010, 65:1539-1540.
35. Smet A., Martel A., Persoons D., Dewulf J., Heyndrickx M., Claeys G., et al. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections. Microb Drug Resist 2010, 16:129-134.
36. Pullinger G.D., Lax A.J. A Salmonella dublin virulence plasmid locus that affects bacterial growth under nutrient-limited conditions. Mol Microbiol 1992, 6:1631-1643.
37. Damjanova I., Tóth A., Pászti J., Hajbel-Vékony G., Jakab M., Berta J., et al. Expansion and countrywide dissemination of ST11, ST15, and ST147 ciprofloxacin-resistant CTX-M-15-type β-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005 - the new 'MRSAs'?. J Antimicrob Chemother 2008, 62:978-985.
38. Oteo J., Cuevas O., López-Rodríguez I., Banderas-Florido A., Vindel A., Pérez-Vázquez M., et al. Emergence of CTX-M-15-producing Klebsiella pneumoniae of multilocus sequence types 1, 11, 14, 17, 20, 35 and 36 as pathogens and colonizers in newborns and adults. J Antimicrob Chemother 2009, 64:524-552.